Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy

Journal of Heart and Lung Transplantation

Volumn 23, Issue 11, 2004, Pages 1260-1265

  Kutschka, Ingo ^a   Pethig, Klaus ^b   Harringer, Wolfgang ^a   Haverich, Axel ^c   Strüber, Martin ^c  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HOMOCYSTEINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ALLOGRAFT; ANGIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DYSLIPOPROTEINEMIA; EVALUATION; FEMALE; GRAFT REJECTION; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARAMETER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECIPIENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STENOSIS; VASCULAR DISEASE;

CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; HEART TRANSPLANTATION; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 8144226776     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.09.004     Document Type: Article

References (37)

1. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation Eighteenth official report - 2001. J Heart Lung Transplant. 20:2001;805-815
2. Pethig K., Klauss V., Heublein B., et al. Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound Correlation to immunological and non-immunological risk factors. Heart. 84:2000;494-498
3. Ip J.H., Fuster V., Badimon L., Badimon J., Taubman M.B., Chesebro J.H. Syndromes of accelerated atherosclerosis Role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 15:1990;1667-1687
4. Schmid C., Kerber S., Baba H.A., Deng M., Hammel D., Scheld H.H. Graft vascular disease after heart transplantation. Eur Heart J. 18:1997;554-559
5. Weis M., von Scheidt W. Cardiac allograft vasculopathy. A review. Circulation. 96:1997;2069-2077
6. Luyt C.E., Drobinski G., Dorent R., et al. Prognosis of moderate coronary artery lesions in heart transplant patients. J Heart Lung Transplant. 22:2003;130-136
7. Libby P., Tanaka H. The pathogenesis of coronary arteriosclerosis ("chronic rejection")in transplanted hearts. Clin Transpl. 8:1994;313-318
8. Eich D., Thompson J.A., Ko D.J., Hastillo A., Lower R., Katz S. Hypercholesterolemia in long-term survivors of heart transplantation An early marker of accelerated coronary artery disease. J Heart Lung Transplant. 10:1991;45-49
9. Pethig K., Heublein B., Kutschka I., Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy-high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation. 102:(suppl 3):2000;233-236
10. Seshadri N., Robinson K. Homocysteine, B vitamins, and coronary artery disease. Med Clin North Am. 84:2000;215-237
11. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Eng J Med. 337:1997;230-236
12. Kark J.D., Selhub J., Adler B., et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med. 131:1999;321-330
13. Bostom A.G., Rosenberg I.C.H., Silbershatz H. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons The framingham study. Ann Intern Med. 131:1999;352-355
14. Kutschka I., Pethig K., Strüber M., Dieterich C., Harringer W., Haverich A. Homocysteine - a treatable risk factor for allograft vascular disease after heart transplantation? J Heart Lung Transplant. 20:2001;743-746
15. Gupta A., Moustapha A., Jacobsen D.W., et al. High homocysteine, low folate, and low vitamin B6 concentrations prevalent risk factors for vascular disease in heart transplant recipients. Transplantation. 65:1998;544-550
16. Ambrosi P., Garcon D., Riberi A., et al. Association of mild hyperhomocysteinemia with cardiac graft vascular disease. Atherosclerosis. 138:1998;347-350
17. Pethig K., Besser K., Heublein B., Wahlers T., Harringer W., Haverich A. Coronary vasculopathy after heart transplantation - effect of temporal onset, severity and progression on long-term prognosis. Z Kardiol. 88:1999;498-506
18. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 338:1998;1042-1050
19. Tawakol A., Omland T., Gerhard M., Wu J.T., Creager M.A. Hyperhomocyst (e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 95:1997;1119-1121
20. Tang L., Mamotte C.D., Van Bockxmeer F.M., Taylor R.R. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle. Atherosclerosis. 136:1998;169-173
21. Rees M.M., Rodgers G.M. Homocysteinemia Association of a metabolic disorder with vascular disease and thrombosis. Thromb Res. 71:1993;337-359
22. Brattstrom L., Wilcken D.E.L., Ohrvik J., Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease The result of a meta-analysis. Circulation. 98:1998;2520-2526
23. Bostom A.G., Lathrop L. Homocysteinemia in end-stage renal disease Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 52:1997;10-20
24. Selhub J., Jaques P.F., Rosenberg I.H. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994); population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 131:1999;331-339
25. Potena L., Grigioni F., Magnani G., et al. Increasing plasma homocysteine during follow-up in heart transplant recipients Effects of folate and renal function. Ital Heart J. 1:2000;344-348
26. Hauptman P.J., Davis S.F., Miller L., Yeung A.C. The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: Preliminary insights from a multicenter intravascular ultrasound transplant study. multicenter intravascular ultrasound transplant study group. J Heart Lung Transplant. 14:1995;238-242
27. Cook R., Tupper J., Parker S., et al. Effect of immunosuppressive therapy, serum creatinine and time after transplant on plasma homocysteine in patients following heart transplantation. J Heart Lung Transplant. 18:1999;420-424
28. Ducloux D., Fournier V., Rebibou J.M., Bresson-Vautrin C., Gibey R., Chalopin J.M. Hyperhomocyst (e) inemia in renal transplant recipients with and without cyclosporine. Clin Nephrol. 49:1998;232-235
29. Berger P.B., Jones J.D., Olson L.J., et al. Increase in total plasma homocysteine concentration after cardiac transplantation. Mayo Clin Proc. 70:1995;125-131
30. Frequin S.T., Wevers R.A., Braam M., Barkhof F., Hommes O.R. Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high dose intravenous methylprednisolone. J Neurol. 240:1993;305-308
31. Ubbink J.B., Fehily A.M., Pickering J., Elwood P.C., Hayward Vermaak W.J. Homocysteine and ischemic heart disease in the Caerphilly cohort. Atherosclerosis. 140:1998;349-356
32. Verhoef P., Stampfer M.J., Buring J.E., et al. Homocysteine metabolism and risk of myocardial infarction Relation with vitamins b6, b12 and folate. Am J Epidemiol. 143:1996;845-859
33. Hankey G.J., Eikelboom J.W. Homocysteine and vascular disease. Lancet. 354:1999;407-413
34. Wilcken D.E.L., Dudman N.P.B., Tyrrell P.A., Robertson M.R. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency Possible implications for prevention of vascular disease. Metabolism. 37:1988;697-701
35. Schnyder G., Roffi M., Pin R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 345:2001;1593-1600
36. Yamani M.H., Tuzcu E.M., Starling R.C., et al. Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound. J Heart Lung Transplant. 21:2002;850-859
37. Mehra M.R., Ventura H.O., Uber P.A., Scott R.L., Park M.H. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox. J Heart Lung Transplant. 22:2003;118-123